These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 546799)

  • 61. The window period between hepatitis B e antigen and antibody in chronic type hepatitis.
    Liaw YF; Huang MJ; Chu CM; Sheen IS; Lin DY
    Hepatology; 1984; 4(4):619-21. PubMed ID: 6745849
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Hepatitis Be antigen and antibody in hepatitis B surface antigen positive blood donors.
    Barr A; Black SH; Burrell CJ; Dow B; Macvarish I
    J Clin Pathol; 1979 Feb; 32(2):132-5. PubMed ID: 108319
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Epidemiology of hepatitis B e antigen and antibody in mentally retarded HBsAg carriers.
    Lohiya G; Lohiya S; Ngo VT; Crinella R
    Hepatology; 1986; 6(2):163-6. PubMed ID: 2937706
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Variable expression of preS1 antigen in serum during chronic hepatitis B virus infection: an accurate marker for the level of hepatitis B virus replication.
    Petit MA; Zoulim F; Capel F; Dubanchet S; Dauguet C; Trepo C
    Hepatology; 1990 May; 11(5):809-14. PubMed ID: 2347555
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Demonstration of hepatitis B virus DNA by polymerase chain reaction in the serum and the liver after spontaneous or therapeutically induced HBeAg to anti-HBe or HBsAg to anti-HBs seroconversion in patients with chronic hepatitis B.
    Loriot MA; Marcellin P; Bismuth E; Martinot-Peignoux M; Boyer N; Degott C; Erlinger S; Benhamou JP
    Hepatology; 1992 Jan; 15(1):32-6. PubMed ID: 1727796
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [Natural history of the state of asymptomatic carrier of HBsAg: 7-year follow-up].
    Antoniozzi F; Meucci G; Vecchi M; Ronchi G; Collatina R; Del Ninno E; de Franchis R
    Boll Ist Sieroter Milan; 1986; 65(5):347-53. PubMed ID: 3828089
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Sites that bind polymerized albumin on hepatitis B surface antigen particles: detection by radioimmunoassay.
    Hansson BG; Purcell RH
    Infect Immun; 1979 Oct; 26(1):125-30. PubMed ID: 500199
    [TBL] [Abstract][Full Text] [Related]  

  • 68. [Delta infection in HBsAg carriers].
    Hess G; Slusarczyk J; Hansson BG; Dienes HP; Baumann W; Meyer zum Büschenfelde KH
    Z Gastroenterol; 1984 Dec; 22(12):692-6. PubMed ID: 6396986
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Binding activity of HBsAg particles from chronic HBsAg carriers to polystyrene beads coated with polymerized human serum albumin: diagnostic relevance of the assay.
    Hopf U; Möller B; Schermer M; Lobeck H
    Liver; 1984 Dec; 4(6):372-8. PubMed ID: 6394944
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Hepatitis B e antigen and antibody measured by radioimmunoassay in acute hepatitis B surface antigen-positive hepatitis.
    Aldershvile J; Frösner GG; Nielsen JO; Hardt F; Deinhardt F; Skinhøj P
    J Infect Dis; 1980 Mar; 141(3):293-8. PubMed ID: 7365280
    [TBL] [Abstract][Full Text] [Related]  

  • 71. A large-scale survey on the prevalence of HBeAG and anti-HBe among asymptomatic carriers of HBV. Correlation with sex, age, HBsAG titre and s-GPT value.
    Sasaki T; Hattori T; Mayumi M
    Vox Sang; 1979; 37(4):216-21. PubMed ID: 494592
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Radioimmunoassay for the detection of HBeAg and anti-HBe.
    Zanetti AR; Ferroni P; Bonino F; Recchia S; Aricò S; Palla M; Caspani B
    Boll Ist Sieroter Milan; 1979 Jan; 57(6):811-5. PubMed ID: 95390
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Frequency and persistence of serologic markers following three different manifestations of hepatitis B virus infection.
    Wilkinson R
    Vox Sang; 1983; 45(2):121-8. PubMed ID: 6613079
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Incidences of HBeAg and anti-HBe in, and clinical course of hepatitis B virus carriers.
    Tsuchie H; Kurimura O; Tamura I; Shimase K; Kaneto E; Kurimura T; Tsuda F; Mayumi M
    Biken J; 1984 Dec; 27(4):169-76. PubMed ID: 6100353
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Relevance of HBe/anti-HBe system and DNA polymerase activity in chronic hepatitis-B virus carriers on haemodialysis. A prospective study.
    Marchesini G; Zoli M; Angiolini A; Feliciangeli G; Santoro A; Ferroni P; Zanetti AR
    Nephron; 1981; 29(1-2):44-8. PubMed ID: 7329473
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Hepatitis B virus DNA in anti-HBe-positive asymptomatic carriers.
    Seo Y; Yoon S; Nakaji M; Yano Y; Nagano H; Ninomiya T; Hayashi Y; Kasuga M
    Intervirology; 2003; 46(1):43-9. PubMed ID: 12566698
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Seroconversion from hepatitis B e antigen to antibody in chronic type B hepatitis.
    Hoofnagle JH; Dusheiko GM; Seeff LB; Jones EA; Waggoner JG; Bales ZB
    Ann Intern Med; 1981 Jun; 94(6):744-8. PubMed ID: 7235415
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [e/Anti-e system in liver disease].
    Resta ML; Freni MA; Berlinghieri G; Ajello A; Crinò M; Ferraù O
    Boll Soc Ital Biol Sper; 1980 Oct; 56(20):2123-8. PubMed ID: 7459125
    [TBL] [Abstract][Full Text] [Related]  

  • 79. [Specific circulating immune complexes in patients with hepatitis B].
    Chang ML; Chou CT; Chao YC; Lee CF; Chang DM; Hsu K
    Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1987 May; 20(2):119-26. PubMed ID: 3652780
    [TBL] [Abstract][Full Text] [Related]  

  • 80. HBeAg/anti-HBe antigenic system in liver diseases in Greece.
    Theodoropoulos G; Nakopoulou L; Fertakis A; Papaevangelou G; Hadzis G; Kasfiki A
    Hepatogastroenterology; 1983 Dec; 30(6):243-5. PubMed ID: 6327477
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.